ISSN 2412-4036 (print)
ISSN 2713-1823 (online)

The possibilities of early diagnosis and progression of non-radiographic axial spondyloarthritis (experience of Kaliningrad region)

Grabovetskaya Yu.Yu., Smirnov A.V., Mikhailov E.S., Shcherbanev K.G.

1) Regional Clinical Hospital of Kaliningrad Region, Kaliningrad; 2) V.A. Nasonova Research Institute of Rheumatology, Moscow
Abstract. The diagnosis of spondyloarthritis (SpA) is often delayed, that is resulted from several factors like the absence of specific manifestations of SpA in the early stages, insufficient alertness of physicians of related specialties, patients late seek medical care, etc. The introduction of the concept of ”non-radiographic axial spondyloarthritis” (nr-axSpA) increased the total number of patients with SpA, but did not lead to a significant reduction in the time for diagnosis and a reduction in the burden of the disease.
The aim of the study was conducting an experience with the participation of physicians of various specialties and a reference center for V.A. Nasonova Research Institute of Rheumatology for the purpose of early detection of patients with nr-axSpA and subsequent dynamic follow-up.
Material and methods. 284 physicians of different specialties have been informed the early symptoms of axSpA. 361 patients were directed to rheumatologist consultation. Nr-axSpA were diagnosed in 80 of 361 patients. Then we compared 80 patients with nr-axSpA and 99 patients with ankylosing spondylitis (AS) with an average duration of the disease of 14 years.
Results. The study included 80 patients with nr-axSpA diagnosed on ASAS 2009 criteria. The diagnosis was reclassified to AS in 12 (15%) by specialists of the reference center of the Nasonova Research Institute of Rheumatology reviewed the MRI and X-ray data. After 3 years of observation, 30 of 68 (44%) patients had clinical manifestations consistent with nr-axSpA, 16/68 (23.5%) were diagnosed with AS, 7/68 (10.3%) – psoriatic spondyloarthritis, in 13/68 (14.7%) SpA was excluded, 2/68 (3%) dropped out of participation due to loss of contact. Women (61.5%) prevailed among patients with nr-axSpA, men (74.7%) prevailed in AS. HLA-B27 was detected in 39.7% of patients with nr-axSpA. Significant differences in disease activity between nr-axSpA and AS patients weren’t reveled.
Conclusions. The conducted experience in Kaliningrad region have demonstrated the effectiveness of attracting related specialists for early diagnostics of the nr-axSpA, as well as the existing difficulties in interpreting radiological data at the early stages of the disease and the need to use a reference center for a federal institution.

Keywords

non-radiographic axial spondyloarthritis
ankylosing spondylitis
radiography
magnetic resonance imaging
reference center for spondyloarthritis

References

1. Мазуров В.И., Гайдукова И.З. Современная концепция спондилоартритов. Opinion Leader. 2019;(9):18–29. (Mazurov VI, Gaidukova IZ. Modern concept of spondyloarthritis. Opinion Leader. 2019;(9):18–29 (In Russ.)). EDN: NNTINE.

2. Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection.Ann Rheum Dis. 2009;68(6):777–83.

https://doi.org/10.1136/ard.2009.108233. Erratum in: Ann Rheum Dis. 2019;78(6):e59. https://doi.org/10.1136/ard.2009.108233corr1. PMID: 19297344.

3. Zhao SS, Pittam B, Harrison NL, Ahmed AE, Goodson NJ, Hughes DM. Diagnostic delay in axial spondyloarthritis: A systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(4):1620–28.

PMID: 33428758. https://doi.org/10.1093/rheumatology/keaa807

4. Boonen A, Sieper J, van der Heijde D, Dougados M, Bukowski JF, Valluri S et al. The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2015;44(5):556–62.

PMID: 25532945. https://doi.org/10.1016/j.semarthrit.2014.10.009

5. Румянцева Д.Г., Дубинина Т.В., Демина А.Б., Румянцева О.А., Агафонова Е.М., Смирнов А.В., Эрдес Ш.Ф. Анкилозирующий спондилит и нерентгенологический аксиальный спондилоартрит: две стадии одной болезни? Терапевтический архив. 2017;89(5):33–37. (Rumyantseva DG, Dubinina TV, Demina AB, Rumyantseva OA, Agafonova EM, Smirnov AV, Erdes ShF. Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease? Terapevticheskiyarkhiv = Therapeutic Archive. 2017;89(5):33–37 (In Russ.)).

EDN: YSYUOT. https://doi.org/10.17116/terarkh201789533-37

6. Braun J, Baraliakos X, Hermann KG, Landewe R, Machado PM, Maksymowych WP et al. Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis. RMD Open. 2017;3(1):e000430.

PMID: 28848654. PMCID: PMC5566980. https://doi.org/10.1136/rmdopen-2017-000430

7. Deodhar A, Blanco R, Dokoupiloa E, Hall S, Kameda H, Kivitz AJ et al. Improvement of signs and symptoms of nonradiographic axial spondyloarthritis in patients treated with secukinumab: Primary results of a randomized, placebo-controlled phase III study. Arthritis Rheumatol. 2021;73(1):110–20.

PMID: 32770640. PMCID: PMC7839589. https://doi.org/10.1002/art.41477

8. Inman RD. Axial spondyloarthritis: Current advances, future challenges. J Rheum Dis. 2021;28(2):55–59.

PMID: 37476012. PMCID: PMC10324891. https://doi.org/10.4078/jrd.2021.28.2.55

9. Protopopov M, Poddubnyy D. Radiographic progression in non-radiographic axial spondyloarthritis. Expert Rev Clin Immunol. 2018;14(6):525–33.

PMID: 29774755. https://doi.org/10.1080/1744666X.2018.1477591

10. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369–74.

PMID: 21622969. https://doi.org/10.1136/ard.2010.145995

11. Wang R, Gabriel SE, Ward MM. Progression of nonradiographic axial spondyloarthritis to ankylosing spondylitis: A population-based cohort study. Arthritis Rheumatol. 2016;68(6):1415–21.

PMID: 26663907. PMCID: PMC5025639. https://doi.org/10.1002/art.39542

12. Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: Update by the ASAS MRI working group. Ann Rheum Dis. 2016;75(11):1958–63.

PMID: 26768408. https://doi.org/10.1136/annrheumdis-2015-208642

13. Machado P, Landewe RB, Braun J, Baraliakos X, Hermann KG, Hsu B et al. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. AnnRheumDis. 2012;71(12):2002–5.

PMID: 22915615. https://doi.org/10.1136/annrheumdis-2012-201999

14. https://kaliningrad.gks.ru/statistical_news/document/159880 (дата обращения – 09.07.2023).

15. Дубинина Т.В., Эрдес Ш.Ф. Причины поздней диагностики анкилозирующего спондилита в клинической практике. Научно-практическая ревматология. 2010;48(2):43–48. (Dubinina TV, Erdes ShF. Reasons for late diagnosis of ankylosing spondylitis in clinical practice. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2010;48(2):43–48 (In Russ.)). EDN: MNIKKB.

16. Afinogenova Y, Alexander S, Maheshwari N, Kiwalkar S, Danve A. Awareness and attitudes regarding axial spondyloarthritis among primary care providers (abstract). Arthritis Rheumatol. 2021;73 (Suppl_9). URL: https://acrabstracts.org/abstract/awareness-and-attitudes-regarding-axial-spondyloarthritis-among-primary-care-providers (date of accessed – 14.02.2026).

17. van Onna M, Gorter S, van Meerendonk A, van Tubergen A. General practitioners’ perceptions of their ability to identify and refer patients with suspected axial spondyloarthritis: A qualitative study. JRheumatol. 2014;41(5):897–901.

PMID: 24692524. https://doi.org/10.3899/jrheum.131293

18. Mathieson HR, Merashli M, Gaffney K, Marzo-Ortega H; BRITSpA (British Society for Spondyloarthritis). Poor awareness of inflammatory back pain and axial spondyloarthritis among secondary care specialists. Clin Rheumatol. 2016;35(10):2627–28.

PMID: 27180070. https://doi.org/10.1007/s10067-016-3305-y

19. Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53(4):650–57.

PMID: 24324212. https://doi.org/10.1093/rheumatology/ket387

20. Jamal M, van Delft ETAM, den Braanker H, Kuijper TM, Hazes JMW, Lopes Barreto D, Weel AEAM. Increase in axial spondyloarthritis diagnoses after the introduction of the ASAS criteria: A systematic review. Rheumatol Int. 2023;43(4):639–49.

PMID: 36637486. https://doi.org/10.1007/s00296-022-05262-6

21. Sykes MP, Doll H, Sengupta R, Gaffney K. Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? Rheumatology (Oxford). 2015;54(12):2283–84.

PMID: 26283680. https://doi.org/10.1093/rheumatology/kev288

22. Zhao SS, Pittam B, Harrison NL, Ahmed AE, Goodson NJ, Hughes DM. Diagnostic delay in axial spondyloarthritis: A systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(4):1620–28.

PMID: 33428758. https://doi.org/10.1093/rheumatology/keaa807

23. Dougados M, Demattei C, van den Berg R, Vo Hoang V, Thevenin F, Reijnierse M et al. Rate and predisposing factors for sacroiliac joint radiographic progression after a two-year follow-up period in recent-onset spondyloarthritis. Arthritis Rheumatol. 2016;68(8):1904–13.

PMID: 26990518. PMCID: PMC5129505. https://doi.org/10.1002/art.39666

24. Dougados M, Sepriano A, Molto A, van Lunteren M, Ramiro S, de Hooge M et al. Sacroiliac radiographic progression in recent onset axial spondyloarthritis: The 5-year data of the DESIR cohort. Ann Rheum Dis. 2017;76(11):1823–28.

PMID: 28684556. PMCID: PMC5705846. https://doi.org/10.1136/annrheumdis-2017-211596

25. Lopez-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: A comparison by systematic literature review and meta-analysis. RMD Open. 2019;5(2):e001108.

PMID: 31803500. PMCID: PMC6890393. https://doi.org/10.1136/rmdopen-2019-001108

26. Kishimoto M, Ono K, Fukui S, Kawaai S, Deshpande GA, Yoshida K et al. Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: Results of the cross-sectional ASAS-COMOSPA study. RMD Open. 2021;7(3):e001752.

PMID: 34531305. PMCID: PMC8449957. https://doi.org/10.1136/rmdopen-2021-001752

27. Braun J, Kiltz U, Baraliakos X, van der Heijde D. Optimisation of rheumatology assessments – the actual situation in axial spondyloarthritis including ankylosing spondylitis. Clin Exp Rheumatol. 2014;32(5 Suppl_85):S-96–104.PMID: 25365096.

28. Baraliakos X, Hermann KG, Braun J. Imaging in axial spondyloarthritis: Diagnostic problems and pitfalls. Rheum Dis Clin North Am. 2012;38(3):513–22.

PMID: 23083752. https://doi.org/10.1016/j.rdc.2012.08.011

About the Authors

Yulia Yu. Grabovetskaya, MD, chief freelance rheumatologist of the Ministry of Healthcare of Kaliningrad Region, head of Anti-cytokine Therapy Center, Regional Clinical Hospital of Kaliningrad Region. Address: 236016, Kaliningrad, 74 Klinicheskaya St.
E-mail: dr.grabovetskaya@mail.ru
ORCID: https://orcid.org/0000-0003-1758-3065
Alexander V. Smirnov, MD, Dr. Sci. (Medicine), leading researcher at the Department of instrumental diagnostics, V.A. Nasonova Research Institute of Rheumatology; professor of the Department of radiology and ultrasound diagnostics, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of FMBA. Address: 115682, Moscow, 28 Orekhovy Boulevard.
E-mail: smirale@mail.ru
ORCID: https://orcid.org/0000-0001-7418-9369
Evgeny S. Mikhailov, MD, PhD (Medicine), radiologist at Regional Clinical Hospital of Kaliningrad Region. Address: 236016, Kaliningrad, 74 Klinicheskaya St.
E-mail: esmikhailov@gmail.com
ORCID: https://orcid.org/0009-0005-7357-3912
Kirill G. Shcherbanev, MD, therapist, rheumatologist at Anti-cytokine Therapy Center, Regional Clinical Hospital of Kaliningrad Region. Address: 236016, Kaliningrad, 74 Klinicheskaya St.
E-mail: sherbanev1997@mail.ru
ORCID: https://orcid.org/0000-0002-4230-1974

Similar Articles